¼¼°èÀÇ °æÇÇ ¾à¹°Àü´Þ ½ÃÀå
Transdermal Drug Delivery
»óǰÄÚµå : 1544121
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 179 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ °æÇÇ ¾à¹°Àü´Þ ½ÃÀåÀº 2030³â±îÁö 2,353¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 806¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ °æÇÇ ¾à¹°Àü´Þ ½ÃÀåÀº 2023-2030³â CAGR 16.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 2,353¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÆÐ½Ãºê µô¸®¹ö¸®´Â CAGR 15.1%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1,235¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾×Ƽºê µô¸®¹ö¸® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 18.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 221¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 15.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °æÇÇ ¾à¹°Àü´Þ ½ÃÀåÀº 2023³â¿¡ 221¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 356¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 15.7%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 15.1%¿Í 14.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °æÇÇ ¾à¹°Àü´Þ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°æÇÇ ¾à¹°Àü´ÞÀ̶õ ¹«¾ùÀ̸ç, ¿Ö Áß¿äÇѰ¡?

°æÇÇ ¾à¹°Àü´ÞÀ̶õ Àü½Å È¿°ú¸¦ ¾ò±â À§ÇØ ÇǺθ¦ ÅëÇØ ¾à¹°À» Á¦¾îµÈ ¹æ½ÄÀ¸·Î Åõ¿©ÇÏ´Â ¹æ¹ýÀÔ´Ï´Ù. ÀÌ ¾à¹°Àü´Þ ½Ã½ºÅÛÀº ºñħ½ÀÀûÀÌ°í Æí¸®Çϸç È¿°úÀûÀÎ ¹æ¹ýÀ¸·Î ¼ÒÈ­°üÀ» ¿ìȸÇÏ¿© ¾à¹°À» Ç÷·ù·Î Á÷Á¢ Àü´ÞÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °æÇÇ ÆÐÄ¡´Â °æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ °¡Àå ÀϹÝÀûÀÎ ÇüÅÂÀÌ¸ç ¸¸¼º ÅëÁõ, È£¸£¸ó ºÒ±ÕÇü, ´ÏÄÚÆ¾ Áßµ¶ µî ´Ù¾çÇÑ Áõ»óÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. °æÇÇ ¾à¹°Àü´ÞÀÇ Á߿伺Àº ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ°í ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÁÙÀ̸ç Àå±â°£¿¡ °ÉÃÄ Ä¡·á ¾à¹° ¼öÁØÀ» ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡ ÀÖ½À´Ï´Ù.

°æÇÇÀû ¾à¹°Àü´ÞÀº ¾î¶»°Ô Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö Àִ°¡?

°æÇÇ ¾à¹°Àü´ÞÀº ¾à¹°À» Á¦¾îµÈ »óÅ·ΠÁö¼ÓÀûÀ¸·Î ¹æÃâÇÏ¿© Ä¡·á °á°ú¸¦ °³¼±ÇÕ´Ï´Ù. ÀÌ Àü´Þ ¹æ¹ýÀ» ÅëÇØ ¾à¹°ÀÌ ¾ÈÁ¤ÀûÀÎ ¼Óµµ·Î Èí¼öµÇ¾î Ç÷·ù¿¡¼­ ÃÖÀûÀÇ Ä¡·á ¼öÁØÀ» À¯ÁöÇÕ´Ï´Ù. ¼ÒÈ­°üÀ» ¿ìȸÇÔÀ¸·Î½á °æÇÇ ½Ã½ºÅÛÀº À§ ÀÚ±Ø ¹× ù ¹øÂ° Åë°ú ´ë»ç µîÀÇ ¹®Á¦¸¦ ÇÇÇÏ°í ¾à¹°ÀÌ Àü½Å ¼øÈ¯¿¡ µµ´ÞÇϱâ Àü¿¡ ºÐÇØµÉ ¼ö ÀÖ´Â °¡´É¼ºÀ» ÇÇÇÕ´Ï´Ù. µû¶ó¼­ »ýü ÀÌ¿ë·üÀÌ Çâ»óµÇ°í ÇÊ¿äÇÑ º¹¿ë·®ÀÌ °¨¼ÒÇÕ´Ï´Ù. ¶ÇÇÑ °æÇÇ ÆÐÄ¡´Â »ç¿ëÀÌ °£ÆíÇϰí ÀÚ°¡ Åõ¿©°¡ °¡´ÉÇϹǷΠó¹æµÈ Ä¡·á ¿ä¹ý¿¡ ´ëÇÑ È¯ÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡µéÀº Á¾ÇÕÀûÀ¸·Î º¸´Ù È¿°úÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Ä¡·á °á°ú¿¡ ±â¿©ÇÕ´Ï´Ù.

°æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

°æÇÇ ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä´Â ¸î °¡Áö Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àå±âÀûÀÎ ¾à¹° °ü¸®°¡ ÇÊ¿äÇÑ ¸¸¼ºÁúȯ ¹× ÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ Æí¸®Çϰí È¿°úÀûÀÎ ¾à¹°Àü´Þ ¹æ¹ý¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾à¹° Á¦Çü°ú ÇǺΠħÅõ ±â¼úÀÇ ¹ßÀüÀ¸·Î °æÇÇ Åõ¿© °¡´ÉÇÑ ¾à¹°ÀÇ ¹üÀ§°¡ ³Ð¾îÁö°í Àû¿ë °¡´É¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ°í ºó¹øÇÑ Åõ¿© ¿ä¹ýÀÇ ºÎ´ãÀ» ÁÙÀ̱â À§ÇÑ ³ë·Âµµ °æÇÇ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °æÇÇ ¾à¹°Àü´ÞÀÇ ºñħ½À¼ºÀº Áֻ糪 °æ±¸¿ë ¾à¹°À» ÇÇÇÏ°í ½ÍÀº ȯÀڵ鿡°Ô ¸Å·ÂÀûÀÎ ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. »õ·Î¿î °æÇÇ ±â¼úÀÇ °³¹ß°ú ÇコÄÉ¾î ¾÷°è¿¡¼­ °æÇÇ ½Ã½ºÅÛÀÇ ¼ö¿ëÀÌ È®´ëµÊ¿¡ µû¶ó °æÇÇ ½Ã½ºÅÛÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

°æÇÇ ¾à¹°Àü´Þ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

°æÇÇ ¾à¹°Àü´Þ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ ¹× Àå±âÀûÀÎ ¾à¹° Åõ¿©°¡ ÇÊ¿äÇÑ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÌ°í Æí¸®ÇÑ ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾à¹° Á¦Çü, ÇǺΠħÅõ ÃËÁøÁ¦ ¹× ÆÐÄ¡ µðÀÚÀÎ ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀº °æÇÇ Àü´Þ ½Ã½ºÅÛÀÇ È¿°ú¿Í ¹üÀ§¸¦ È®ÀåÇÏ°í ±× Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ È¯ÀÚÀÇ ¼øÀÀµµ Çâ»ó¿¡ ´ëÇÑ °ü½É°ú ºñħ½ÀÀû ¾à¹°Àü´Þ ¿É¼Ç¿¡ ´ëÇÑ ´ÏÁîµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÅëÁõ °ü¸®, È£¸£¸ó ´ëü ¿ä¹ý, ±Ý¿¬ µî °æÇÇ Èí¼ö½Ã½ºÅÛÀÇ ¿ëµµ°¡ È®´ëµÇ°í ÀÖ´Â °Íµµ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯¸®ÇÑ ±ÔÁ¦ Á¤Ã¥°ú »õ·Î¿î °æÇÇ ±â¼ú °³¹ßÀÌ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î »ê¾÷¿¡¼­ °æÇÇÀû ¾à¹°Àü´Þ¿¡ ´ëÇÑ ¼ö¿ëÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ¼º´É°ú ½Å·Ú¼ºÀ» ³ôÀ̱â À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·ÂÀÌ ½ÃÀå ¼ºÀå ÀáÀç·ÂÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 12°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Transdermal Drug Delivery Market to Reach US$235.3 Billion by 2030

The global market for Transdermal Drug Delivery estimated at US$80.6 Billion in the year 2023, is expected to reach US$235.3 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Passive Delivery, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$123.5 Billion by the end of the analysis period. Growth in the Active Delivery segment is estimated at 18.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$22.1 Billion While China is Forecast to Grow at 15.7% CAGR

The Transdermal Drug Delivery market in the U.S. is estimated at US$22.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$35.6 Billion by the year 2030 trailing a CAGR of 15.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.1% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global Transdermal Drug Delivery Market - Key Trends & Drivers Summarized

What is Transdermal Drug Delivery and Why is it Crucial?

Transdermal Drug Delivery is a method of administering medications through the skin in a controlled manner to achieve systemic effects. This delivery system is crucial for providing a non-invasive, convenient, and effective way of delivering drugs directly into the bloodstream, bypassing the gastrointestinal tract. Transdermal patches are the most common form of transdermal drug delivery systems, used to treat various conditions such as chronic pain, hormonal imbalances, and nicotine addiction. The significance of transdermal drug delivery lies in its ability to improve patient compliance, reduce the risk of side effects, and maintain consistent therapeutic drug levels over extended periods.

How Does Transdermal Drug Delivery Improve Therapeutic Outcomes?

Transdermal Drug Delivery improves therapeutic outcomes by offering a controlled and sustained release of medication. This delivery method ensures that drugs are absorbed at a steady rate, maintaining optimal therapeutic levels in the bloodstream, which enhances efficacy and reduces the frequency of dosing. By bypassing the gastrointestinal tract, transdermal systems avoid issues such as gastric irritation and first-pass metabolism, which can degrade the drug before it reaches systemic circulation. This leads to better bioavailability and reduced dosage requirements. Additionally, transdermal patches are user-friendly and can be self-administered, improving patient adherence to prescribed treatment regimens. These benefits collectively contribute to more effective and reliable therapeutic outcomes.

Why is the Demand for Transdermal Drug Delivery Systems Increasing?

The demand for Transdermal Drug Delivery systems is increasing due to several key factors. The rising prevalence of chronic diseases and conditions that require long-term medication management drives the need for convenient and effective drug delivery methods. Advances in drug formulation and skin penetration technologies have expanded the range of drugs that can be delivered transdermally, increasing their applicability. The focus on improving patient compliance and reducing the burden of frequent dosing regimens also fuels the demand for transdermal systems. Additionally, the non-invasive nature of transdermal drug delivery makes it an attractive option for patients who prefer to avoid injections or oral medications. The development of novel transdermal technologies and the growing acceptance of these systems in the healthcare industry further support their adoption.

What Factors are Driving the Growth of the Transdermal Drug Delivery Market?

The growth in the Transdermal Drug Delivery market is driven by several factors. The increasing prevalence of chronic diseases and conditions requiring long-term medication creates a significant demand for effective and convenient drug delivery systems. Technological advancements in drug formulation, skin penetration enhancers, and patch design enhance the efficacy and range of transdermal delivery systems, driving their adoption. The focus on improving patient compliance and the need for non-invasive drug delivery options also contribute to market growth. The expanding applications of transdermal systems, including pain management, hormone replacement therapy, and smoking cessation, further boost demand. Additionally, favorable regulatory policies and the development of novel transdermal technologies support market expansion. The growing acceptance of transdermal drug delivery in the healthcare industry, coupled with ongoing research and development efforts to enhance their performance and reliability, underscores the market's potential for growth.

Select Competitors (Total 12 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â